GB1330545A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- GB1330545A GB1330545A GB3475871A GB3475871A GB1330545A GB 1330545 A GB1330545 A GB 1330545A GB 3475871 A GB3475871 A GB 3475871A GB 3475871 A GB3475871 A GB 3475871A GB 1330545 A GB1330545 A GB 1330545A
- Authority
- GB
- United Kingdom
- Prior art keywords
- thiourea
- thiazolyl
- pharmaceutical preparations
- july
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 3
- VQTRGMDNNYNBNG-UHFFFAOYSA-N 1,1-diethyl-3-(1,3-thiazol-2-yl)thiourea Chemical compound CCN(CC)C(=S)NC1=NC=CS1 VQTRGMDNNYNBNG-UHFFFAOYSA-N 0.000 abstract 1
- FIGRRRXEUUOHRS-UHFFFAOYSA-N 1,1-dimethyl-3-(4-methyl-1,3-thiazol-2-yl)thiourea Chemical compound CN(C)C(=S)NC1=NC(C)=CS1 FIGRRRXEUUOHRS-UHFFFAOYSA-N 0.000 abstract 1
- ZAWPTHKVMMXVTH-UHFFFAOYSA-N 1-methyl-3-(1,3-thiazol-2-yl)thiourea Chemical compound CNC(=S)NC1=NC=CS1 ZAWPTHKVMMXVTH-UHFFFAOYSA-N 0.000 abstract 1
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 230000000078 anti-malarial effect Effects 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
1330545 Pharmaceutical preparations F HOFFMANN-LA ROCHE & CO AG 23 July 1971 [24 July 1970] 34758/71 Heading ASB Pharmaceutical preparations possessing antimalarial activity, influencing amine metabolism and lowering blood-pressure, in closage unit form, contain 1,1-diethyl-3-(2-thiazolyl)-2- thiourea, 1-methyl-3-(2-thiazolyl)-2-thiourea, or 1,1-dimethyl-3-(4-methyl-2-thiazolyl)-2-thiourea and/or a pharmaceutically acceptable acid addition salt of such a compound in admixture with a compatible pharmaceutical carrier. The preparations may be administered orally, rectally or parenterally in the form of tablets, dragees, suppositories, capsules, solutions, suspensions or emulsions which may also contain other therapeutically voluable substances.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1124070 | 1970-07-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1330545A true GB1330545A (en) | 1973-09-19 |
Family
ID=4371509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3475871A Expired GB1330545A (en) | 1970-07-24 | 1971-07-23 | Pharmaceutical preparations |
Country Status (8)
| Country | Link |
|---|---|
| AU (1) | AU3041671A (en) |
| BE (1) | BE770403A (en) |
| DE (1) | DE2137045A1 (en) |
| FR (1) | FR2100948B1 (en) |
| GB (1) | GB1330545A (en) |
| IL (1) | IL37235A (en) |
| NL (1) | NL7108189A (en) |
| ZA (1) | ZA714076B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL102548A (en) * | 1991-08-02 | 1998-08-16 | Medivir Ab | Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds |
| US5593993A (en) * | 1991-08-02 | 1997-01-14 | Medivir Ab | Method for inhibition of HIV related viruses |
-
1971
- 1971-06-15 NL NL7108189A patent/NL7108189A/xx unknown
- 1971-06-22 ZA ZA714076A patent/ZA714076B/en unknown
- 1971-06-24 AU AU30416/71A patent/AU3041671A/en not_active Expired
- 1971-07-05 IL IL37235A patent/IL37235A/en unknown
- 1971-07-22 FR FR7126840A patent/FR2100948B1/fr not_active Expired
- 1971-07-23 DE DE19712137045 patent/DE2137045A1/en active Pending
- 1971-07-23 BE BE770403A patent/BE770403A/en unknown
- 1971-07-23 GB GB3475871A patent/GB1330545A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE2137045A1 (en) | 1972-01-27 |
| AU3041671A (en) | 1973-01-04 |
| IL37235A (en) | 1973-10-25 |
| ZA714076B (en) | 1972-03-29 |
| IL37235A0 (en) | 1971-10-20 |
| BE770403A (en) | 1972-01-24 |
| FR2100948A1 (en) | 1972-03-24 |
| NL7108189A (en) | 1972-01-26 |
| FR2100948B1 (en) | 1974-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1161439A (en) | Pharmaceutical Compositions | |
| GB1198764A (en) | A Urate Oxidase and process for the production thereof | |
| GB1491503A (en) | Method of preventing and treating thrombosis | |
| PH10478A (en) | 3-substituted alkyleneamines having 5,6 or 7-ring members and pharmaceutical preparations containing them | |
| GB1330545A (en) | Pharmaceutical preparations | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1291559A (en) | N-(4-chlorocinnamoyl)-4-hydroxypiperidine | |
| GB1346405A (en) | Pharmaceutical composition useful as an anti-depressant agent and an anti-parkinsonism agent | |
| GB1324532A (en) | Pharmaceutical preparations | |
| GB1322301A (en) | Purine-ribonucleoside derivatives | |
| GB1305179A (en) | ||
| IL76380A0 (en) | Benzazole derivatives,processes for their production and pharmaceutical preparations containing such compounds and the use thereof | |
| IE35711L (en) | Pharmaceutical compositions | |
| GB1293329A (en) | Pharmaceutical compositions | |
| GB1355033A (en) | Antimalarial medicines comprising thiazolyl thioureas | |
| GB1477509A (en) | Pharmaceutical compositions containing a thiazole derivative | |
| GB1268398A (en) | Pharmaceutical compositions | |
| ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
| GB1375847A (en) | ||
| GB1272452A (en) | Pharmaceutical preparations comprising a thioacetamide derivative | |
| IE35226B1 (en) | Pharmaceutical preparations | |
| GB1217138A (en) | Pharmaceutical compositions based on derivatives of benzimidazole | |
| IE33519B1 (en) | Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process | |
| GB1152677A (en) | Improved Anabolic Agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |